[Genetic differences in mice in the sensitivity to the immunodepressive action of alkylating agents]

Area of Science:

• Immunology
• Pharmacology
• Toxicology

Background:

• Alkylating agents like cyclophosphamide are used in cancer therapy but can suppress the immune system.
• Understanding inter-strain differences in immune response to these agents is crucial for optimizing treatment and predicting side effects.

Purpose of the Study:

• To investigate the immunodepressant effects of cyclophosphamide, thiophosphamide, and sarcolysine.
• To compare the sensitivity of different mouse strains to these alkylating agents' immunosuppressive actions.

Main Methods:

• Experimental primary immune response induction using sheep red blood cells in mice.
• Administration of cyclophosphamide, thiophosphamide, and sarcolysine.
• Assessment of immune response differences across mouse strains (DBA/2, C3H/Sn, BALB/c).

Main Results:

• DBA/2 and C3H/Sn mice exhibited significant sensitivity to the immunosuppressive effects of the tested alkylating agents.
• BALB/c mice demonstrated relative resistance to the immunodepressant actions of cyclophosphamide, thiophosphamide, and sarcolysine.
• Significant inter-strain variations in immune response to alkylating agents were observed.

Conclusions:

• Mouse strain genetic background influences susceptibility to alkylating agent-induced immunosuppression.
• BALB/c mice may be a more suitable model for studying immune responses in the presence of certain alkylating agents.
• Further research is warranted to elucidate the mechanisms underlying these observed inter-strain differences.